rss
J Med Ethics 2000;26:363-369 doi:10.1136/jme.26.5.363

British community pharmacists' views of physician-assisted suicide (PAS)

  1. Timothy R G Hanlon,
  2. Marjorie C Weiss,
  3. Judith Rees
  1. University of Bristol and University of Manchester

      Abstract

      Objectives— To explore British community pharmacists' views on PAS , including professional responsibility, personal beliefs, changes in law and ethical guidance.

      Design— Postal questionnaire

      Setting— Great Britain

      Subjects— A random sample of 320 registered full-time community pharmacists

      Results— The survey yielded a response rate of 56%. The results showed that 70% of pharmacists agreed that it was a patient's right to choose to die, with 57% and 45% agreeing that it was the patient's right to involve his/her doctor in the process and to use prescription medicines, respectively. Forty-nine per cent said that they would knowingly dispense a prescription for use in PAS were it to be legalised and 54% believed it correct to refuse to dispense such a prescription. Although 53% believed it to be their right to know when they were being involved in PAS, 28% did not. Most pharmacists (90%) said that they would wish to see the inclusion of a practice protocol for PAS in the code of ethics of the Royal Pharmaceutical Society of Great Britain (CE-RPSGB) in the event of a change in the law on PAS. In addition, 89% would wish to see PAS included in the Conscience Clause of the CE-RPSGB. Males were found to be significantly less likely to favour PAS than females (p<0.05), as were those declaring an ethnic/religious background of consideration when dealing with ethical issues in practice compared with their counterparts (p<0.00005).

      Conclusion— Pharmacists view their professional responsibility in PAS to be more obligatory than a physician's, in having to provide the means for PAS. It is worrying that a proportion of the respondents prefer to remain in ignorance of the true purpose of a prescription for PAS; a finding at odds with current developments within the pharmaceutical profession. A practice protocol for PAS and an extension of the conscience clause should be considered in the event of PAS becoming legal. Such measures would allow the efficient provision of the pharmaceutical service whilst at the same respecting the personal beliefs of those who object to cooperating in the ending of a life.

      Footnotes

      • Timothy R G Hanlon, MSc, MRPharmS, is a Hospital Pharmacist and a Former MSc student. Marjorie C Weiss, MSc (Clinical Pharmacy), MSc (Social Research Methods), DPhil, MRPharmS, is Lecturer in Primary Care, University of Bristol, Whiteladies Road, Bristol BS8 2PR. Judith Rees, PhD, MRPharmS, is Senior Lecturer in Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester. Address for correspondence: M C Weiss.

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.